These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 19924738)
1. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738 [TBL] [Abstract][Full Text] [Related]
2. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells. Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439 [TBL] [Abstract][Full Text] [Related]
3. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery. Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409 [TBL] [Abstract][Full Text] [Related]
4. The packaging of siRNA within the mesoporous structure of silica nanoparticles. Li X; Xie QR; Zhang J; Xia W; Gu H Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804 [TBL] [Abstract][Full Text] [Related]
5. Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier. Wang J; Dou B; Bao Y Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():98-109. PubMed ID: 24268238 [TBL] [Abstract][Full Text] [Related]
6. Surface engineering of gold nanoparticles for in vitro siRNA delivery. Zhao E; Zhao Z; Wang J; Yang C; Chen C; Gao L; Feng Q; Hou W; Gao M; Zhang Q Nanoscale; 2012 Aug; 4(16):5102-9. PubMed ID: 22782309 [TBL] [Abstract][Full Text] [Related]
7. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990 [TBL] [Abstract][Full Text] [Related]
8. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908 [TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126 [TBL] [Abstract][Full Text] [Related]
10. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells. Mimi H; Ho KM; Siu YS; Wu A; Li P J Control Release; 2012 Feb; 158(1):123-30. PubMed ID: 22094103 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932 [TBL] [Abstract][Full Text] [Related]
12. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348 [TBL] [Abstract][Full Text] [Related]
13. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
14. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes]. Yang H; Che O; Chen S; Sun L; Ji AM Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758 [TBL] [Abstract][Full Text] [Related]
15. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells. Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Kim SH; Mok H; Jeong JH; Kim SW; Park TG Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275 [TBL] [Abstract][Full Text] [Related]
17. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles. Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699 [TBL] [Abstract][Full Text] [Related]
18. Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells. Guo J; O'Driscoll CM; Holmes JD; Rahme K Int J Pharm; 2016 Jul; 509(1-2):16-27. PubMed ID: 27188645 [TBL] [Abstract][Full Text] [Related]
19. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928 [TBL] [Abstract][Full Text] [Related]
20. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery. Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]